"Adrenocortical Adenoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.
| Descriptor ID |
D018246
|
| MeSH Number(s) |
C04.588.322.078.265.500 C19.053.098.265.500 C19.053.347.500.500 C19.344.078.265.500
|
| Concept/Terms |
Adrenocortical Adenoma- Adrenocortical Adenoma
- Adenomas, Adrenocortical
- Adrenocortical Adenomas
- Adenoma, Adrenocortical
- Adenoma, Adrenal Cortical
- Adenomas, Adrenal Cortical
- Adrenal Cortical Adenoma
- Adrenal Cortical Adenomas
Conn Adenoma- Conn Adenoma
- Adenoma, Conn
- Adenomas, Conn
- Conn Adenomas
- Conn's Disease
- Conns Disease
- Disease, Conn's
- Conn Disease
- Disease, Conn
|
Below are MeSH descriptors whose meaning is more general than "Adrenocortical Adenoma".
Below are MeSH descriptors whose meaning is more specific than "Adrenocortical Adenoma".
This graph shows the total number of publications written about "Adrenocortical Adenoma" by people in this website by year, and whether "Adrenocortical Adenoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 0 | 2 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenocortical Adenoma" by people in Profiles.
-
Adrenal histologic and genetic characteristics of primary aldosteronism in late adulthood. Eur J Endocrinol. 2026 Feb 04; 194(2):208-216.
-
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas. J Clin Endocrinol Metab. 2024 Dec 18; 110(1):195-207.
-
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study. J Clin Endocrinol Metab. 2024 Aug 13; 109(9):e1750-e1758.
-
High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment. Eur J Endocrinol. 2023 Sep 01; 189(3):318-326.
-
Deep learning approach for differentiating indeterminate adrenal masses using CT imaging. Abdom Radiol (NY). 2023 10; 48(10):3189-3194.
-
Differentiating between adrenocortical carcinoma and lipid-poor cortical adenoma: A novel cross-sectional imaging-based score. Surgery. 2023 Jan; 173(1):35-42.
-
Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting. J Clin Endocrinol Metab. 2021 10 21; 106(11):3320-3330.
-
Abnormal body composition in patients with adrenal adenomas. Eur J Endocrinol. 2021 Oct 08; 185(5):653-662.
-
Frailty in Patients With Mild Autonomous Cortisol Secretion is Higher Than in Patients with Nonfunctioning Adrenal Tumors. J Clin Endocrinol Metab. 2020 09 01; 105(9).
-
An ectopic renin-secreting adrenal corticoadenoma in a child with malignant hypertension. Physiol Rep. 2016 Mar; 4(5).